Lord, Abbett & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-375,399
| Closed | -$19.4M | – | 599 |
|
|
2022
Q2 | $19.4M | Buy |
375,399
+12,649
| +3% | +$655K | 0.07% | 336 |
|
|
2022
Q1 | $26.4M | Sell |
362,750
-584,084
| -62% | -$42.4M | 0.07% | 334 |
|
|
2021
Q4 | $112M | Sell |
946,834
-103,965
| -10% | -$12.3M | 0.26% | 120 |
|
|
2021
Q3 | $141M | Buy |
1,050,799
+159,899
| +18% | +$21.5M | 0.34% | 82 |
|
|
2021
Q2 | $144M | Buy |
890,900
+211,759
| +31% | +$34.3M | 0.35% | 78 |
|
|
2021
Q1 | $54.5M | Buy |
+679,141
| New | +$54.5M | 0.14% | 232 |
|
|
2019
Q4 | – | Sell |
-265,382
| Closed | -$3.54M | – | 718 |
|
|
2019
Q3 | $3.54M | Sell |
265,382
-17,904
| -6% | -$239K | 0.01% | 653 |
|
|
2019
Q2 | $4.64M | Sell |
283,286
-75,742
| -21% | -$1.24M | 0.02% | 657 |
|
|
2019
Q1 | $6.13M | Buy |
359,028
+108,825
| +43% | +$1.86M | 0.02% | 633 |
|
|
2018
Q4 | $3.42M | Buy |
250,203
+85,124
| +52% | +$1.16M | 0.01% | 698 |
|
|
2018
Q3 | $4.73M | Buy |
+165,079
| New | +$4.73M | 0.01% | 740 |
|